Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.400
+0.020 (1.45%)
At close: Nov 10, 2025, 4:00 PM EST
1.400
0.00 (0.00%)
After-hours: Nov 10, 2025, 4:00 PM EST
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $11.32 million as of November 10, 2025. Its market cap has increased by 18.23% in one year.
Market Cap
11.32M
Enterprise Value
11.52M
1-Year Change
18.23%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $11.32M, a decrease of -97.28%. That is a compound annual growth rate of -40.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 11.24M | -28.44% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | 84.01M | -81.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |